PRODUCTS SOLD BY ASCEND PEPTIDES ARE INTENDED FOR RESEARCH USE ONLY.
PRODUCTS SOLD BY ASCEND PEPTIDES ARE INTENDED FOR RESEARCH USE ONLY.
⚠ Important – Reconstitution Requirement
This product requires Acetic Acid Water (AA Water) for proper laboratory reconstitution.
Do not use standard bacteriostatic water as the intended reconstitution solution for this product.
Please ensure you have suitable Acetic Acid Water available before purchasing.
For laboratory research use only. Not for human consumption.
CJC-1295 Without DAC 5mg is supplied as a lyophilised research peptide for laboratory research applications. Each vial contains 5mg of CJC-1295 Without DAC (Mod GRF 1-29) and is supplied from UK stock. For research purposes only.
Form: Lyophilized peptide powder
Safety Information: Not intended for human or veterinary use. Use appropriate laboratory safety procedures when handling.
CJC-1295 WITHOUT DAC 5mg should only be used in laboratory settings by qualified personnel.
Ensure all experimental procedures comply with local and institutional regulations.
This peptide is supplied for research and scientific study purposes only.
Research use only • Must be 18 or over to purchase • UK dispatch • Orders before 4pm ship same day • Secure checkout
CJC-1295 Without DAC 5mg
CJC-1295 Without DAC 5mg is the 5mg format of CJC-1295 Without DAC, also referred to commercially as Mod GRF 1-29.
It is supplied as a lyophilised peptide powder in a single sealed vial from UK stock, for laboratory research purposes only. This format suits pilot investigations, method validation and smaller experimental designs, while the larger CJC-1295 Without DAC 10mg vial remains available for extended research programmes.
CJC-1295 Without DAC is a synthetic 29-amino acid analogue of growth hormone releasing hormone (GHRH), carrying four amino acid substitutions that increase resistance to DPP-IV enzymatic degradation relative to the native GHRH(1-29) sequence. In laboratory models it is studied as an agonist at the GHRH receptor (GHRHR) expressed on anterior pituitary somatotroph cells.
Research interest in the compound centres on GHRH receptor signalling and on the short-acting activity profile associated with the non-DAC structure. It appears in published work examining interactions between the GHRH and growth hormone secretagogue pathways, which act through separate receptors. This information is provided as research context describing how the compound is studied in the literature; it does not describe any outcome in humans.
The terms “with DAC” and “without DAC” refer to structurally different research materials rather than to different strengths of the same compound. The DAC (Drug Affinity Complex) modification adds a chemical group that binds serum albumin, substantially extending the circulating half-life reported in the research literature. The non-DAC form carries no such modification and is correspondingly much shorter acting in study models.
The two materials are therefore not interchangeable, and researchers should confirm which one their experimental protocol specifies before ordering. CJC-1295 With DAC 10mg is listed separately, and a fuller structural comparison is set out in the CJC-1295 With DAC vs Without DAC guide.
IMPORTANT: CJC-1295 Without DAC requires Acetic Acid solution for reconstitution. Reconstitute with Acetic Acid Water (AA Water) for research use. Do not use standard bacteriostatic water as the intended reconstitution solution for this product. Gently swirl. Aliquot immediately.
Please ensure suitable Acetic Acid 10ml is available before beginning research. Preparation volumes and laboratory procedures remain the responsibility of the researcher.
Store the lyophilised powder refrigerated between 2–8°C. Handle using appropriate laboratory safety procedures. Not intended for human or veterinary use. Further handling information is available in the Peptide Storage Guide.
Prohibited at all times under WADA and UKAD regulations.
For in-vitro laboratory research only. Not for human consumption. Not an MHRA-licensed medicine.
CJC-1295 Without DAC 5mg is supplied exclusively for in-vitro laboratory research. It is not a medicine, is not an MHRA-licensed product, and is not supplied or marketed for diagnostic, therapeutic or clinical use in humans or animals. It should only be handled in laboratory settings by qualified personnel, and all experimental procedures must comply with local and institutional regulations.
A curated entry point for buyers comparing quality, documentation, and availability.
UK same-day dispatch – Secure
payment options –
Laboratory research only
© 2026 by Ascend Peptides Uk.
All products sold by Ascend Peptides UK are intended strictly for laboratory research purposes only. Not intended for human consumption or therapeutic use of any kind.
